Department of Genetics, Harvard Medical School, New Research Building, Boston, MA, 02115, USA.
Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA, 02115, USA.
Sci Rep. 2020 Oct 9;10(1):16902. doi: 10.1038/s41598-020-74035-7.
Epidemiological studies have suggested differences in the rate of multiple sclerosis (MS) in individuals of European ancestry compared to African ancestry, motivating genetic scans to identify variants that could contribute to such patterns. In a whole-genome scan in 899 African-American cases and 1155 African-American controls, we confirm that African-Americans who inherit segments of the genome of European ancestry at a chromosome 1 locus are at increased risk for MS [logarithm of odds (LOD) = 9.8], although the signal weakens when adding an additional 406 cases, reflecting heterogeneity in the two sets of cases [logarithm of odds (LOD) = 2.7]. The association in the 899 individuals can be fully explained by two variants previously associated with MS in European ancestry individuals. These variants tag a MS susceptibility haplotype associated with decreased CD58 gene expression (odds ratio of 1.37; frequency of 84% in Europeans and 22% in West Africans for the tagging variant) as well as another haplotype near the FCRL3 gene (odds ratio of 1.07; frequency of 49% in Europeans and 8% in West Africans). Controlling for all other genetic and environmental factors, the two variants predict a 1.44-fold higher rate of MS in European-Americans compared to African-Americans.
流行病学研究表明,欧洲血统个体的多发性硬化症 (MS) 发病率与非洲血统个体存在差异,这促使人们进行遗传扫描以识别可能导致这种模式的变异。在对 899 名非裔美国病例和 1155 名非裔美国对照进行全基因组扫描后,我们证实,在 1 号染色体位置继承了欧洲血统基因组片段的非裔美国人患 MS 的风险增加 [对数优势 (LOD) = 9.8],尽管当增加另外 406 例时信号会减弱,反映了两组病例的异质性 [对数优势 (LOD) = 2.7]。在这 899 名个体中,关联可以完全用两个先前与欧洲血统个体中的 MS 相关的变体来解释。这些变体标记了一个与 CD58 基因表达降低相关的 MS 易感性单倍型(在欧洲人中,标记变体的频率为 84%,在西非人中为 22%),以及 FCRL3 基因附近的另一个单倍型(比值比为 1.07;在欧洲人中的频率为 49%,在西非人中的频率为 8%)。控制所有其他遗传和环境因素后,这两个变体预测欧洲裔美国人患 MS 的比率比非裔美国人高 1.44 倍。